SCHEMBL16965314

SCHEMBL16965314

O=C(O)NCc1cccc(-c2ccc(C(F)(F)F)nn2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ TRPA1 O75762 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ POLB P06746 1/20 0.42
▸ AOC3 Q16853 2/20 0.42
▸ CYP2C19 P33261 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ CARM1 Q86X55 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CFD P00746 1/20 0.39
▸ PTGER4 P35408 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16894164 0.84 BRD4 (0.45) SYKTRPA1CYP1A2CYP2C9L3MBTL1
SCHEMBL18290410 0.82 CARM1 (0.43) SYKTRPA1CARM1
SCHEMBL16965183 0.81 SYK (0.45) SYKTRPA1TSHRPOLBAOC3
SCHEMBL16894280 0.77 SYK (0.47) SYKCFDCNR2
SCHEMBL22501674 0.76 CTSV (0.52) TSHRAOC3CYP2C19CYP1A2CYP2D6
SCHEMBL16965275 0.74 AOC3 (0.47) SYKTSHRAOC3CYP2C19CYP1A2
SCHEMBL19917661 0.74 TRPA1 (0.43) SYKGAATRPA1POLBTP53
SCHEMBL22501881 0.73 AOC3 (0.45) GAATSHRAOC3CYP2C19CYP1A2
SCHEMBL30661718 0.72 MLYCD (0.65) GAACYP2C19CYP1A2CYP2D6L3MBTL1
SCHEMBL16906662 0.72 SDHB (0.52) TSHRCYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900642-A1 SUBSTITUTED SULFONAMIDE COMPOUNDS F. Hoffmann-La Roche AG (CH) 2015-08-05 — — EP disclosed
Send feedback